In the BioHarmony Drug Report Database

"Preview" Icon

Cerivastatin

Baycol (cerivastatin) is a small molecule pharmaceutical. Cerivastatin was first approved as Baycol on 1997-06-26. It is used to treat coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, and hypertriglyceridemia in the USA. The pharmaceutical is active against 3-hydroxy-3-methylglutaryl-Coenzyme A reductase.

 

Trade Name

 

Baycol
 

Common Name

 

cerivastatin
 

ChEMBL ID

 

CHEMBL1477
 

Indication

 

coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia
 

Drug Class

 

Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)

Image (chem structure or protein)

Cerivastatin structure rendering